- Title
- A novel genetic and morphologic phenotype of ARID2-mediated myelodysplasia
- Creators
- H Sakai - Cleveland ClinicN Hosono - Cleveland ClinicH Nakazawa - Shinshu UniversityB Przychodzen - Cleveland ClinicC Polprasert - Cleveland ClinicH E Carraway - Cleveland ClinicM A Sekeres - Cleveland ClinicT Radivoyevitch - Cleveland ClinicK Yoshida - The University of TokyoM Sanada - The University of TokyoT Yoshizato - Kyoto UniversityK Kataoka - The University of TokyoM M Nakagawa - Kyoto UniversityH Ueno - Kyoto UniversityY Nannya - Kyoto UniversityA Kon - The University of TokyoY Shiozawa - The University of TokyoJ Takeda - Kyoto UniversityY Shiraishi - The University of TokyoK Chiba - The University of TokyoS Miyano - The University of TokyoJ Singh - Cleveland ClinicR A Padgett - Cleveland ClinicS Ogawa - Kyoto UniversityJ P Maciejewski - Cleveland ClinicH Makishima - Cleveland Clinic
- Publication Details
- Leukemia, Vol.32(3), pp.839-843
- Grant note
- S10 RR019391 / NCRR NIH HHS K24 HL077522 / NHLBI NIH HHS U54 RR019397 / NCRR NIH HHS R01 HL082983 / NHLBI NIH HHS
- Academic Unit
- Miller School of Medicine; UMMG Dept of Medicine - Hematology/Oncology
- Language
- English
- Resource Type
- Journal article
- PMID
- 29099495
- Record Identifier
- 991031757364502976
Journal article
A novel genetic and morphologic phenotype of ARID2-mediated myelodysplasia
Leukemia, Vol.32(3), pp.839-843
2018-03
PMID: 29099495
Metrics
5 Record Views
InCites Highlights
These are selected metrics from InCites Benchmarking & Analytics tool, related to this output
- Collaboration types
- Domestic collaboration
- International collaboration
- Citation topics
- 1 Clinical & Life Sciences
- 1.103 Blood Disorders
- 1.103.155 Acute Myeloid Leukemia
- Web Of Science research areas
- Hematology
- Oncology
- ESI research areas
- Clinical Medicine
UN Sustainable Development Goals (SDGs)
This output has contributed to the advancement of the following goals:
Source: InCites